José Ortiz, CEO of PVpharm will be participating as a trainer, in the next EVWeb training on 29 Janyary 2 February 2024. The training will be delivered online in the morning time (9:00-13:30 CET).
The training is targeted to:
-Users who have to report and analyse suspected adverse reactions in the pre- and post-authorisation phase using the ISO/ICH E2B(R3) ICSR format
-Users of EudraVigilance – new users and users already trained on working with EudraVigilance
-Professionals performing electronic transmission of ICSRs, who operate as Gateway traders or as WebTrader (i.e., who use EVWEB or EV Post)
-Sponsors of Clinical Trials
-National Competent Authorities or those acting on their behalf, in charge of pharmacovigilance and drug safety with obligations to report suspected adverse reactions related to medicines
Please read more and register in the link below:
PVpharm is also organizing in-house trainings in pharmacovigilance for pharmaceutical companies and CROs, please contact us for further information.
